FAST NEWS: Hutchmed Receives Additional Holdings from U.S. Fund
The latest: The Capital Group Companies, Inc., a U.S.-based fund disclosed it purchased 1.285 million shares in Hutchmed (China) Ltd. (HCM.US; 0013.HK) for HK$22.14 million ($2.84 million), raising its stake…
Recent Articles
RELATED ARTICLES
-
NEWS WRAP: Hutchmed sells non-core asset to focus on cancer treatment
0013.HK HCM.US
-
Inmagene Bio charts backdoor to U.S. listing with offshore acquisition
IKNA.US
-
BRIEF: Feihe buys additional 100 million yuan in wealth management products
6186.HK
- Hong Kong builds ‘patient capital’ ecosystem to foster technology
-
BRIEF: Hutchmed profit falls on shrinking R&D income
0013.HK HCM.US
-
Cash-hungry Mabwell seeks financial tonic from Hong Kong investors
688062.SHG
-
Seyond may get stuck in slow-moving SPAC lane to Hong Kong listing
7855.HK
Discover hidden China stock gems in our weekly newsletter